Assistant Professor at the Faculty of Pharmacy, University of Manitoba, Canada. President of the Womenís Health Research Foundation of Canada. Member of the Manitoba Drug Standards and Therapeutics Committee. Academic Editor of PLOS ONE. Board member of the Association of Faculties of Pharmacy of Canada.
Chancellor's Fellow, The School of Health in Social Science, The University of Edinburgh. Recipient of the 2011 Yvonne Carter Award for Outstanding New Researcher. Academic Editor for PLoS ONE.
Mainly involved in the discovery of new bioactive compounds from Antarctic and Arctic bacteria. Also working on on Antarctic psychrophilic microorganisms with potential biotechnological applications, and the dissection of the virulence determinants of some human pathogens by the use of non-vertebrate host model, like Caenorhabtidis elegans.
PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). Now I make HIV and other diagnostic devices in a small biotech company.
Professor of Biomaterials at Department of Materials Engineering of University of Tokyo. Joint appointment in Medical School of University of Tokyo as Professor of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine. Editorial of Journal of Biomaterials Science, Polymer Edition. Associate Editor of Biomacromolecules. Associate Editor of Biomaterials. Recipient of the 2012 Humboldt Research Award. President of Controlled Release Society.
Yeong Yeh Lee, MD PhD FACP FRCP FACG. He currently holds a faculty position with the School of Medical Sciences, Universiti Sains Malaysia. He also holds research positions at the University of Glasgow and Georgia Regents University. Dr. Lee is actively involved in research related to gastroenterology and internal medicine. He is editor of BMC Gastroenterology, Journal of Royal College of Physicians of Edinburgh (JRCPE) and Malaysian Journal of Medical Sciences (MJMS).
James B. Duke Professor of Biomedical Engineering at Duke University. Recipient of the 2012 Clemson Award for Applied Research.
Professor of Chemical Engineering at the National University of Singapore. Recipient of the 1996 National Science Award of Singapore.
Tenured Scientist (Associate Professor) at Institute of Catalysis - The Spanish National Research Council (CSIC). Fellow of the RSC. Membership of AAAS, Program Excellence in Science in 2005.
Vice President of Drug Discovery at Infectious Disease Research Institute.
Affiliate Professor, Global Health, University of Washington.
Senior Editor of Microbiology (SGM, UK).
Editorial Board for PLOS ONE and Frontiers in Cell and Infection Microbiology.
Professor of Pharmacology, Head of School of Pharmacy and Pharmaceutical Sciences and Director of Cancer Drug Discovery Center Trinity College Dublin Ireland. A highly-cited pharmacologist, recipient of Scientist of Canadian Institutes of Health Research, Trinity College Dublin Fellow and Complutense University Madrid Honorary Doctorate awards.
Professor of Pharmacology and Psychiatry, University of Toronto. Discovered the antipsychotic receptor, now termed the dopamine D2 receptor. He has received 25 awards (Lieber Award, Ariens Receptor award, Dean Award, Prix Galien award, Pasarow Award, Killam Prize, Order of Canada).